These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32201519)

  • 21. miR-125b-5p/STAT3 Pathway Regulated by mTORC1 Plays a Critical Role in Promoting Cell Proliferation and Tumor Growth.
    Zhang C; Wan X; Tang S; Li K; Wang Y; Liu Y; Sha Q; Zha X; Liu Y
    J Cancer; 2020; 11(4):919-931. PubMed ID: 31949495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-432 Suppresses Invasion and Migration via E2F3 in Nasopharyngeal Carcinoma.
    Wang T; Du M; Zhang W; Bai H; Yin L; Chen W; He X; Chen Q
    Onco Targets Ther; 2019; 12():11271-11280. PubMed ID: 31908492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minicircle-oriP-miR-31 as a Novel EBNA1-Specific miRNA Therapy Approach for Nasopharyngeal Carcinoma.
    Wu J; Tan X; Lin J; Yuan L; Chen J; Qiu L; Huang W
    Hum Gene Ther; 2017 May; 28(5):415-427. PubMed ID: 28042945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma.
    Cheung CC; Lun SW; Chung GT; Chow C; Lo C; Choy KW; Lo KW
    BMC Cancer; 2016 Jul; 16():495. PubMed ID: 27431799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FOXA1 reprograms the TGF-β-stimulated transcriptional program from a metastasis promoter to a tumor suppressor in nasopharyngeal carcinoma.
    Li J; Wang W; Chen S; Cai J; Ban Y; Peng Q; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Yi M; Xiang B
    Cancer Lett; 2019 Feb; 442():1-14. PubMed ID: 30392786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miRNA-125b-5p Suppresses Hypothyroidism Development by Targeting Signal Transducer and Activator of Transcription 3.
    Xiu L; Xing Q; Mao J; Sun H; Teng W; Shan Z
    Med Sci Monit; 2018 Jul; 24():5041-5049. PubMed ID: 30027933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.
    Zheng YQ; Bai YF; Yang S; Cui YR; Wang YP; Hu WL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):207-216. PubMed ID: 30657562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2.
    Xu YF; Mao YP; Li YQ; Ren XY; He QM; Tang XR; Sun Y; Liu N; Ma J
    Cancer Lett; 2015 Jul; 363(2):146-55. PubMed ID: 25892549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
    Jiang N; Jiang X; Chen Z; Song X; Wu L; Zong D; Song D; Yin L; Wang D; Chen C; Bian X; He X
    J Exp Clin Cancer Res; 2017 Oct; 36(1):138. PubMed ID: 28982387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-educated platelet miR-34c-3p and miR-18a-5p as potential liquid biopsy biomarkers for nasopharyngeal carcinoma diagnosis.
    Wang H; Wei X; Wu B; Su J; Tan W; Yang K
    Cancer Manag Res; 2019; 11():3351-3360. PubMed ID: 31114371
    [No Abstract]   [Full Text] [Related]  

  • 32. miR-589-5p inhibits MAP3K8 and suppresses CD90
    Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X
    J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miRNA-17 promotes nasopharyngeal carcinoma radioresistance by targeting PTEN/AKT.
    Hu Z; Zhou S; Luo H; Ji M; Zheng J; Huang F; Wang F
    Int J Clin Exp Pathol; 2019; 12(1):229-240. PubMed ID: 31933738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-122-5p suppresses cell proliferation, migration and invasion by targeting SATB1 in nasopharyngeal carcinoma.
    Liu YH; Liu JL; Wang Z; Zhu XH; Chen XB; Wang MQ
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):622-629. PubMed ID: 30720170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of Insulin-Like Growth Factor-1 Receptor (IGF-1R) Reverses the Inhibitory Effect of Let-7g-5p on Migration and Invasion of Nasopharyngeal Carcinoma.
    Zhao Z; Wen J; Peng L; Liu H
    Med Sci Monit; 2019 Aug; 25():5747-5756. PubMed ID: 31374070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiRNA-125a-5p: a regulator and predictor of gefitinib's effect on nasopharyngeal carcinoma.
    Liu Y; Li Z; Wu L; Wang Z; Wang X; Yu Y; Zhao Q; Luo F
    Cancer Cell Int; 2014 Mar; 14(1):24. PubMed ID: 24602316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.
    Zhang LY; Ho-Fun Lee V; Wong AM; Kwong DL; Zhu YH; Dong SS; Kong KL; Chen J; Tsao SW; Guan XY; Fu L
    Carcinogenesis; 2013 Feb; 34(2):454-63. PubMed ID: 23125220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxanthine guanine phosphoribosyltransferase 1, a target of miR-125b-5p, promotes cell proliferation and invasion in head and neck squamous cell carcinoma.
    Yuan L; Xiao Z; Lu R
    Heliyon; 2023 Sep; 9(9):e20174. PubMed ID: 37810145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-139-5p affects cisplatin sensitivity in human nasopharyngeal carcinoma cells by regulating the epithelial-to-mesenchymal transition.
    Shao Q; Zhang P; Ma Y; Lu Z; Meng J; Li H; Wang X; Chen D; Zhang M; Han Y; Liu H; Ma S
    Gene; 2018 Apr; 652():48-58. PubMed ID: 29427737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-483-5p Predicts Poor Prognosis and Promotes Cancer Metastasis by Targeting
    Li XZ; Tu YJ; Zhou T; Zhang JB; Xiao RW; Yang DW; Zhang PF; You PT; Zheng XH
    Front Oncol; 2021; 11():720835. PubMed ID: 34722264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.